Archive: 01/11/2016

Results from the SENTINEL trial presented

A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device during transcatheter aortic valve replacement (TAVR) found that the device was safe but did not meet the primary efficacy ...

Results from the PARTNER I FIVE YEAR ECHO study presented

A substudy of the PARTNER I Trial and Continued Access Registry found that hemodynamic trends in patients who received transcatheter aortic valve replacement (TAVR) showed excellent durability without significant structural ...

Results of PARTNER II QUALITY OF LIFE study presented

Patients with severe aortic stenosis (AS) at intermediate surgical risk, and who are treated with transcatheter aortic valve replacement (TAVR) had improved health status at one month compared with surgical aortic valve replacement ...

page 7 from 11